In this episode of Phase Forward, Jason Shuris, CBO of Indero (formerly Innovaderm), discusses the company's rebranding to Indero on March 7th, 2025. This change, which coincides with the 25th anniversary, marks an exciting expansion into rheumatology services alongside dermatology. The rebranding leverages Innovaderm's strong reputation in dermatology to introduce the Indero brand globally. The vision includes maintaining core values, scientific excellence, and high-quality service, as a dual-focused CRO.